Combination toxicity of etoposide (VP-16) and photosensitisation with a water-soluble aluminium phthalocyanine in K562 human leukaemic cells
1996

Combining Etoposide and Photosensitization in Leukemia Cells

publication Evidence: moderate

Author Information

Author(s): TG Gantchev, N Brasseur, JE van Lier

Primary Institution: Department of Nuclear Medicine and Radiobiology, Faculty of Medicine, University of Sherbrooke

Hypothesis

Photodynamic therapy (PDT) in conjunction with etoposide could result in enhanced cytotoxicity.

Conclusion

The combination of etoposide and photosensitization showed synergistic toxicity in K562 human leukaemic cells.

Supporting Evidence

  • The combination treatment resulted in supra-additive accumulation of cells in the G2/M phase of the cell cycle.
  • Internucleosomal DNA fragmentation was significantly increased with combined treatment.
  • AlPcS4 photosensitisation was shown to induce oxidative damage to DNA.

Takeaway

Using light to activate a special dye along with a cancer drug can make the drug work better against leukemia cells.

Methodology

K562 human leukaemic cells were treated with etoposide and aluminium tetrasulphonated phthalocyanine, followed by light exposure, and various assays were performed to assess cell viability and DNA fragmentation.

Limitations

The study was conducted in vitro, and the results may not directly translate to clinical settings.

Participant Demographics

K562 human leukaemic cells were used in the study.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication